Market Cap | 2.97B | P/E | - | EPS this Y | 783.30% | Ern Qtrly Grth | 13.20% |
Income | 52.28M | Forward P/E | 29.91 | EPS next Y | 26.40% | 50D Avg Chg | 7.00% |
Sales | 665.99M | PEG | 4.80 | EPS past 5Y | -18.09% | 200D Avg Chg | 5.00% |
Dividend | 9.00% | Price/Book | 1.00 | EPS next 5Y | 7.30% | 52W High Chg | -23.00% |
Recommedations | 2.20 | Quick Ratio | 0.62 | Shares Outstanding | 234.26M | 52W Low Chg | 28.00% |
Insider Own | 1.18% | ROA | 2.71% | Shares Float | 230.85M | Beta | 1.24 |
Inst Own | 93.84% | ROE | 1.83% | Shares Shorted/Prior | 18.85M/11.54M | Price | 12.86 |
Gross Margin | 68.90% | Profit Margin | 7.85% | Avg. Volume | 2,180,485 | Target Price | 18.59 |
Oper. Margin | 38.14% | Earnings Date | Nov 4 | Volume | 1,190,724 | Change | -0.62% |
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2023, Sabra's real estate properties held for investment included 37,606 beds/units, spread across the United States and Canada.
Citigroup | Buy | Sep 13, 24 |
Truist Securities | Buy | Sep 4, 24 |
Scotiabank | Sector Perform | Aug 26, 24 |
Truist Securities | Buy | Jun 27, 24 |
Scotiabank | Sector Perform | May 15, 24 |
Deutsche Bank | Buy | Jan 30, 24 |
Mizuho | Buy | Jan 3, 24 |
Stifel | Buy | Nov 7, 23 |
Wells Fargo | Equal-Weight | Oct 17, 23 |